Implication of STAT3 Signaling in Human Colonic Cancer Cells during Intestinal Trefoil Factor 3 (TFF3) – and Vascular Endothelial Growth Factor–Mediated Cellular Invasion and Tumor Growth

作者: Gérard Redeuilh , Erik Bruyneel , Christian Gespach , Christine Rivat , Sylvie Rodrigues

DOI:

关键词: Neoplastic transformationSignal transductionVascular endothelial growth factorSTAT3Trefoil factor 3Cancer researchOncogeneBiologyGene productSTAT protein

摘要: Signal transducer and activator of transcription (STAT) 3 is overexpressed or activated in most types human tumors has been classified as an oncogene. In the present study, we investigated contribution STAT3s to proinvasive activity trefoil factors (TFF) vascular endothelial growth factor (VEGF) colorectal cancer cells HCT8/S11 expressing VEGF receptors. Both intestinal peptide (TFF3) VEGF, but not pS2 (TFF1), activate STAT3 signaling through Tyr(705) phosphorylation both STAT3alpha STAT3beta isoforms. Blockade by STAT3beta, depletion STAT3alpha/beta isoforms RNA interference, pharmacologic inhibition cucurbitacin inhibitory abrogates TFF- VEGF-induced cellular invasion reduces tumor xenografts athymic mice. Differential gene expression analysis using DNA microarrays revealed that overexpression down-regulates receptors Flt-1, neuropilins 1 2, inhibitor binding/differentiation (Id-2) product involved neoplastic transformation. Taken together, our data suggest TFF3 essential angiogenesis regulator VEGF(165) exert potent cells. We also validate new therapeutic strategies targeting inhibitors interference for treatment patients.

参考文章(41)
Daniel K. Podolsky, Mechanisms of regulatory peptide action in the gastrointestinal tract: trefoil peptides. Journal of Gastroenterology. ,vol. 35, pp. 69- 74 ,(2000)
R Houlgatte, M D Devignes, M N Jumeau, C Bouchier, F Bois, B Lamy, G Behar, S Duprat, C Auffray, C Da Silva, [IMAGE: molecular integration of the analysis of the human genome and its expression]. Comptes Rendus De L Academie Des Sciences Serie Iii-sciences De La Vie-life Sciences. ,vol. 318, pp. 263- 272 ,(1995)
Eric Caldenhoven, Thamar B. van Dijk, Roberto Solari, John Armstrong, Jan A. M. Raaijmakers, Jan-Willem J. Lammers, Leo Koenderman, Rolf P. de Groot, STAT3β, a Splice Variant of Transcription Factor STAT3, Is a Dominant Negative Regulator of Transcription Journal of Biological Chemistry. ,vol. 271, pp. 13221- 13227 ,(1996) , 10.1074/JBC.271.22.13221
Steven P. Rockman, Scott A. Currie, Marianne Ciavarella, Elizabeth Vincan, Chris Dow, Robert J. S. Thomas, Wayne A. Phillips, Id2 Is a Target of the β-Catenin/T Cell Factor Pathway in Colon Carcinoma Journal of Biological Chemistry. ,vol. 276, pp. 45113- 45119 ,(2001) , 10.1074/JBC.M107742200
G J Berx, M M Mareel, G K De Bruyne, F M van Roy, S J Vermeulen, M E Bracke, E A Bruyneel, K M Vennekens, K L Vleminckx, Transition from the Noninvasive to the Invasive Phenotype and Loss of α-Catenin in Human Colon Cancer Cells Cancer Research. ,vol. 55, pp. 4722- 4728 ,(1995)
Carla Boccaccio, Margherita Andò, Luca Tamagnone, Alberto Bardelli, Paolo Michieli, Carlo Battistini, Paolo M. Comoglio, Induction of epithelial tubules by growth factor HGF depends on the STAT pathway Nature. ,vol. 391, pp. 285- 288 ,(1998) , 10.1038/34657
William Dalton, Richard Jove, Robyn Catlett-Falcone, Mark Jaroszeski, Hua Yu, Richard Heller, Guilian Niu, Domenico Coppola, Gene Therapy with Dominant-negative Stat3 Suppresses Growth of the Murine Melanoma B16 Tumor in Vivo Cancer Research. ,vol. 59, pp. 5059- 5063 ,(1999)
M F Di Renzo, S Giordano, M Olivero, A Giacomini, H Porte, S Bottardi, L Mirossay, B Nordlinger, E Chastre, S Bretti, Overexpression and amplification of the Met/HGF receptor gene during the progression of colorectal cancer Clinical Cancer Research. ,vol. 1, pp. 147- 154 ,(1995)
T S Schaefer, L K Sanders, O K Park, D Nathans, Functional differences between Stat3alpha and Stat3beta. Molecular and Cellular Biology. ,vol. 17, pp. 5307- 5316 ,(1997) , 10.1128/MCB.17.9.5307